Tim Lu, Senti Bio

Sen­ti Bio com­pletes its SPAC merg­er, though not be­fore see­ing in­vestors 'play­ing a fi­nan­cial game'

Ed­i­tor’s note: In­ter­est­ed in fol­low­ing bio­phar­ma’s IPO mar­ket? You can book­mark our IPO Track­er here.

De­spite the bear mar­ket cre­at­ing on­go­ing strug­gles in the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.